坦格雷丁通过SSTR4下调抑制LUAD:综合生物信息学和功能验证
Yizhen Yuan1,2,3, Yongfu Wang1,2,3, Wei Liu1,2,3
1School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
肺腺癌 (LUAD) 具有低索马托斯坦素受体4 (SSTR4) 表达,与生存率差相关. 针对格雷丁-SSTR4轴显示了LUAD治疗的治疗潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肺腺癌 (LUAD) 是癌症死亡的主要原因,需要新的治疗策略.
- 尽管已知它们在神经内分泌瘤中的功能,但在LUAD中体静止素受体 (SSTR) 的作用尚不清楚.
研究的目的:
- 研究在LUAD中SSTR4的表达,临床意义和治疗潜力.
- 确定SSTR4的潜在连接体,并阐明潜在的抗瘤机制.
主要方法:
- 对SSTR4表达的公共数据库 (TCGA,GSCA,TIMER) 的分析.
- 使用PRESTO-Tango系统识别SSTR4连接体.
- 功能测试,RNA测序和途径丰富分析.
主要成果:
- 在LUAD组织中,SSTR4表达显著下调.
- 低SSTR4表达与晚期,免疫微环境变化和患者生存率降低相关.
- 坦格雷丁 (TAN) 被确定为SSTR4连接体,其抗瘤作用被SSTR4敲击增强,涉及平衡和能量代谢.
结论:
- 在LUAD中,SSTR4充当瘤抑制剂和预后生物标志物.
- 坦格雷丁-SSTR4信号轴为LUAD提供了一个有前途的治疗标.
更多相关视频
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
10:51Fabrication and Validation of an Organ-on-chip System with Integrated Electrodes to Directly Quantify Transendothelial Electrical Resistance
Published on: September 26, 2017
相关概念视频
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Reliability and Validity
Integration of Rational Functions Using Partial Fractions
Applications of Integration to Probability Density Functions
Data Validation
Key parameters for method validation include:
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
